Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Taxotere docetaxel: Phase III data

In the North American, open-label Phase III TAX 324 trial, induction treatment with Taxotere docetaxel,

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE